A multicentre, randomised controlled trial of cognitive therapy to reduce harmful compliance with command hallucinations

Not Applicable

Completed

• Conditions: Command hallucinations; Mental and Behavioural Disorders; Other symptoms and signs involving general sensations and perceptions

• Registration Number: ISRCTN62304114
• Lead Sponsor: niversity of Birmingham (UK)

Brief Summary

2011 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/21961763 2014 results in: http://www.ncbi.nlm.nih.gov/pubmed/26360400 2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/29909374 (added 18/10/2019)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-03-27
• Study Completion: 2011-01-31
• Last Update Posted: 4 November 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 197

Inclusion Criteria

1. Aged 16-65
2. Primary diagnosis of International Statistical Classification of Diseases and Related Health Problems (ICD-10) schizophrenia or related disorder
3. History of experiencing command hallucinations (minimum 6 months) with risk of harm to self or others

Exclusion Criteria

1. Over 65 years of age
2. Primary diagnosis of organic brain disorder
3. Primary diagnosis of addictive substance misuse
4. Insufficient command of the English language

Study & Design

• Study Type: Interventional
• Study Design: Not specified